---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-111790"
form_type: "8-K"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:50:13.323676+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Aditxt files preliminary proxy for name change to bitXbio and ESPP; outlines digital asset treasury strategy

## Summary
- Filed preliminary proxy for special meeting seeking approval of ESPP and non-binding advisory vote on name change to bitXbio, Inc.
- Plans to create a Digital Asset Treasury comprising crypto reserve, utility token, and tokenized venture representations; no digital asset investments made to date.
- Pearsanta subsidiary announces planned IPO in 2026, subject to market conditions; Evofem focuses on regaining national exchange listing.
- bitXbio strategy aims to connect public markets, blockchain/Web3, and life sciences through a participation-driven model.
- Company currently holds no digital assets; any DAT implementation will depend on available funds and market conditions.

## SEC filing metadata
- accession: 0001213900-25-111790
- form_type: 8-K
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390025111790/0001213900-25-111790-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390025111790/ea0266125-8kdef14a_aditxt.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-111790
- JSON: https://secwatch.observer/filing/0001213900-25-111790.json
- Plain text: https://secwatch.observer/filing/0001213900-25-111790.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.